Biomedix Launches Xchange Population Health Solution
Aggregating & managing data to reduce costs and improve clinical outcomes
Today Biomedix announced the launch of Biomedix Xchange, an advanced population health management solution. Xchange represents the latest addition to the Company’s health information technology portfolio, which includes PADnet and PADnet Xpress diagnostic devices for vascular testing and screening.
“Biomedix has always been on the leading edge of collaborative care,” said John Romans, CEO of Biomedix. “Xchange represents our latest addition, enabling value-based care organizations to securely exchange and report member wellness data between payor, providers and other stakeholders. This web-based platform is designed to support coordinate care delivery and optimize population health.”
“With the shift from RAPS to encounter-based data becoming more important to Medicare Advantage Organizations (MAOs), and Accountable Care Organizations (ACOs) taking on more risk for their populations, Biomedix saw an opportunity to build an integrated technology stack that provides a 360-degree member view through the data generated by diagnostic devices,” stated Rich Delperdang, Chief Growth Officer at Biomedix. “As more and more patients and providers migrate to value-based care arrangements, the need to manage population data effectively and securely becomes increasingly more important.”
Biomedix Xchange also provides longitudinal reporting, enabling value-based care organizations and healthcare professionals to see the progression and status of multiple chronic conditions.
To discover more about Biomedix Xchange, please contact Rich Delperdang, Chief Growth Officer at Biomedix, at firstname.lastname@example.org.
Biomedix is a provider of front-line diagnostic solutions for delivering value-based care. Biomedix Xchange is a population health solution that centralizes data for analyzing population health across multiple chronic conditions. For more information, visit Biomedix.com.
About PADnet & PADnet Xpress
Biomedix is the maker of PADnet, the market leader in front-line diagnostics for peripheral vascular disease. PADnet is the only diagnostic device that can support the identification of PAD and chronic venous insufficiency (CVI) through a unique collaborative care model. PADnet Xpress represents the latest technology for quick and accurate PAD detection, custom-designed for value-based care, including Medicare Advantage Organizations (MAOs).